The Division of Neonatal Medicine and PICU comprises two independent units: the Neonatal and Neonatal Intensive Care Unit (NICU) and the Pediatric Intensive Care Unit (PICU).
The Neonatal and NICU unit was established in 1985. It includes areas for resuscitation and monitoring of critically ill newborns, a general care area for neonates, a preterm infant care area, a phototherapy zone, a neonatal isolation unit, and other auxiliary spaces. It also operates follow-up specialty clinics for newborns and preterm infants. The unit is equipped with various advanced neonatal treatment, resuscitation, and monitoring devices. Medical staff are proficient in neonatal diagnostic and therapeutic procedures, performing techniques such as neonatal resuscitation, mechanical ventilation for respiratory support, circulatory support, enteral and parenteral nutritional support, neonatal exchange transfusion, phototherapy, neuroprotection, umbilical artery/vein catheterization, peripherally inserted central catheter (PICC) placement, and screening and treatment for retinopathy of prematurity (ROP). It has successfully resuscitated extremely low birth weight infants with a gestational age as low as 26 weeks and a birth weight of 650 grams, with long-term follow-up showing no adverse complications. The unit has extensive clinical experience, reaching nationally advanced levels, in managing and treating high-risk infants, including extremely premature infants, neonatal asphyxia, neonatal sepsis and multi-organ failure, severe neonatal jaundice, bronchopulmonary dysplasia in preterm infants, retinopathy of prematurity, and congenital genetic metabolic diseases.
The PICU was established in 2012. It is responsible for the resuscitation and treatment of critically ill and perioperative children. The unit employs advanced technologies such as mechanical ventilation, hemodynamic monitoring, fiberoptic bronchoscopy for diagnosis and intervention, pediatric blood purification, enteral and parenteral nutritional support, and sedation/analgesia. It has achieved a relatively advanced level in diagnosing and treating critically ill children with conditions such as severe infections, respiratory distress syndrome, septic shock, multi-organ failure, and postoperative critical illness. The unit has particularly extensive experience and achieves good clinical outcomes in diagnosing and treating severe complications associated with pediatric hematologic-oncologic diseases and following bone marrow or hematopoietic stem cell transplantation.
The specialty currently has 15 specialist physicians, including 3 with senior professional titles. Among them, 1 holds a doctoral degree and 5 hold master's degrees. Currently, Mai Yougang serves as the Director of the specialty, and Ouyang Ying serves as the Deputy Director.